Skip to Content

Cytovene FDA Alerts

The FDA Alerts below may be specifically about Cytovene or relate to a group or class of drugs which include Cytovene.

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings.

Recent FDA Alerts for Cytovene

Cytovene (gancyclovir)

Healthcare professionals advised of a critical shortage of Cytovene-IV, indicated for the treatment or prevention of cytomegalovirus (CMV) disease. This shortage in supply is expected to last through the second quarter of 2002. Roche urges physicians to explore alternative treatment therapies or management strategies for their patients. This temporary situation affects only the IV formulation of Cytovene.

[March 13, 2002 Letter - Roche]

[Feb 13, 2002 Letter - Roche]

More Cytovene Resources